Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) EBITDA (2019 - 2025)

Historic EBITDA for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$17.6 million.

  • Outset Medical's EBITDA rose 1935.5% to -$17.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$66.7 million, marking a year-over-year increase of 4116.34%. This contributed to the annual value of -$66.7 million for FY2025, which is 4116.34% up from last year.
  • Outset Medical's EBITDA amounted to -$17.6 million in Q4 2025, which was up 1935.5% from -$15.8 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's EBITDA registered a high of -$15.8 million during Q3 2025, and its lowest value of -$45.5 million during Q3 2023.
  • Moreover, its 5-year median value for EBITDA was -$33.6 million (2022), whereas its average is -$32.1 million.
  • Per our database at Business Quant, Outset Medical's EBITDA tumbled by 4683.82% in 2021 and then surged by 5557.27% in 2025.
  • Outset Medical's EBITDA (Quarter) stood at -$40.8 million in 2021, then increased by 2.39% to -$39.8 million in 2022, then increased by 6.2% to -$37.4 million in 2023, then soared by 41.48% to -$21.9 million in 2024, then rose by 19.35% to -$17.6 million in 2025.
  • Its last three reported values are -$17.6 million in Q4 2025, -$15.8 million for Q3 2025, and -$16.9 million during Q2 2025.